Dimethylformamide → HCID 86713734, compound
Reaction equation
[I:1][C:2]1[C:3]([S:11][C:12]2[N:20]=[C:19]3[C:15]([N:16]=[CH:17][NH:18]3)=[C:14](N)[N:13]=2)=[CH:4][C:5]2[O:9][CH2:8][O:7][C:6]=2[CH:10]=1.Br[CH2:23][CH2:24][CH2:25][NH:26][C:27](=[O:31])[CH:28]([CH3:30])[CH3:29].C([O-])([O-])=O.[Cs+].[Cs+].C[N:39](C=O)C>>[NH2:39][C:15]1[N:16]=[CH:17][N:18]=[C:19]2[C:14]=1[N:13]=[C:12]([S:11][C:3]1[C:2]([I:1])=[CH:10][C:6]3[O:7][CH2:8][O:9][C:5]=3[CH:4]=1)[N:20]2[CH2:23][CH2:24][CH2:25][NH:26][C:27](=[O:31])[CH:28]([CH3:30])[CH3:29]Participants
5
Procedure
To a solution of 8-((6-iodobenzo[d][1,3]dioxol-5-yl)thio-9H-purin-6-amine (50 mg, 0.12 mmol) in DMF (2 mL) was added N-(3-bromopropyl)isobutyramide (50 mg, 0.24 mmol) and Cs2CO3 (78 mg, 0.24 mmol). The resulting mixture was stirred at room temperature overnight. The reaction mixture was condensed under vacuum and the residue was purified by Prep TLC (CH2Cl2:NH3-MeOH (7N), 20:1) to yield WS46 as a white solid (22 mg, 34%). 1H NMR (500 MHz, CDCl3/MeOH-d4): δ 8.22 (s, 1H), 7.61 (br s, 1H), 7.41 (s, 1H), 7.08 (s, 1H), 6.07 (s, 2H), 4.27 (m, 2H), 3.21 (m, 2H), 2.45 (s, 1H), 2.02 (m, 2H), 1.19 (d, J=6.9 Hz, 6H); HRMS (ESI) m/z [M+H]+ calcd. for C19H22IN6O3S, 541.0519. found 541.0508.
Workup
- customcondensed under vacuum
- customthe residue was purified by Prep TLC (CH2Cl2:NH3-MeOH (7N), 20:1)
Sources & evidence
- ORD record
- ord-05473eaa9b014ef3b8b42247bd601871
- Source dataset
- uspto-grants-2016_05
- Patent number
- US09346808B2
Reaction notes
Loading…